We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Shining a Light on Drug Development: Revolutionizing Radiolabeling

Article   Nov 09, 2017 | by Laura Elizabeth Mason, Science Editor, Technology Networks

 
Shining a Light on Drug Development: Revolutionizing Radiolabeling

A blue LED shines on a vial containing heavy water, a pharmaceutical compound, and a light-activated catalyst. The new photocatalytic approach from Princeton's David MacMillan turns a multi-month process into a one-day step, speeding the arrival of new drugs to the marketplace. Credit: David MacMillan/Princeton University

 
 
Advertisement
 

RELATED ARTICLES

LC-MS - What Is LC-MS, LC-MS Analysis and LC-MS/MS

Article

Coupling liquid chromatography (LC) with mass spectrometry (MS) has provided scientists with a powerful tool to meet stringent analytical demands and their versatility and efficiency means LC-MS instruments have become desirable in many laboratories. In this article, we consider how LC-MS works, what it tells us and highlight some if the techniques strengths and weaknesses.

READ MORE

Toxicity Studies in Vaccine Clinical Development and Registration

Article

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. This article explores the full process.

READ MORE

Stay Up-to-Date With COVID-19 Vaccine Development

Article

Technology Networks is committed to keeping you updated with the latest research in this space. Here, you'll find a curation of our latest COVID-19 vaccine-related content.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE